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LETTERS TO THE EDITOR
Expression of anti-metastatic gene nm23
Sir - We read with interest the guest editorial by Hart and
Easty (Br. J. Cancer, 1991, 63, 9-12), on the approaches to
the identification and isolation of genes responsible for deter-
mining the metastatic phenotype, and wish to add further
information regarding a specific gene highlighted in the
review.
Expression of the anti-metastatic gene nm23 has been
shown to correlate with the known metastatic potential of
cell lines in murine and rat tumour models. Cotransfection of
rat embryo fibroblasts (REF) with the ras oncogene and the
adenovirus 2 Ela gene was associated with higher levels of
nm23 expression compared to the REF cell lines which were
transfected with the metastasis inducing ras oncogene alone
(Steeg et al., 1988). Two clones of the human nm23 gene
have been identified which are located on chromosome 16
and 17 (Steeg & Liotta, 1990), regions of the latter are
commonly deleted in breast cancer and contain the p53 and
HER2/neu gene loci.
The possible function of the Nm23 protein in tumour
metastasis is discussed in the review. However, more recent
work has given further information, with the Awd/Nm23
protein being identified by immunoblotting in cultured
Drosophila cells, zebra fish embryos, cultured mouse cells,
and demonstrated in Drosophila microtubule preparations
(Biggs et al., 1990). Loss of the Nm23 protein may therefore
cause defects in mitosis and/or protein synthesis due to dis-
ruption of spindle microtubule polymerisation. The exact
mechanism by which the metastatic phenotype may be con-
trolled by the Nm23 protein remains unresolved.
In a limited series of 24 benign and malignant human
breast tumours, nm23 expression was assessed by mRNA
hybridisation and in situ hybridisation, and high levels of
nm23 expression were associated with an absence of lymph
node metastases (Bevilacqua et al., 1989), leading the authors
to suggest that the nm23 gene may suppress the metastatic
phenotype.
We have asssessed the level of nm23 expression in human
primary breast cancers, using the murine pnm23-1 plasmid
and found there was differential expression of the nm23 gene,
with a variation of 120-fold (Hennessy et al., 1991). nm23
mRNA levels from 145 tumours have shown a significant
inverse relationship with lymph node involvement: of 63
tumours from lymph node positive patients 39 (62%) demon-
strated low levels of expression, whereas only 19 out of 46
tumours (41%), from lymph node negative patients, had
similarly low levels (P = 0.032). Low levels of nm23 expres-
sion were seen in poorly differentiated tumours (P = 0.027)
and in oestrogen receptor negative tumours (P =0.054).
There were no significant correlations between nm23 mRNA
expression and tumour size, epidermal growth factor receptor
status, or menopausal status. Also of interest is that there
was no significant correlation between nm23 and HER2/neu
or p53 oncoprotein expression. In the 70 patients who have
been followed-up for greater than 2 years, loss of nm23
expression was associated with disease recurrence (P = 0.003)
and poor patient survival (P = 0.005), and was second only
to nodal status as a significant prognostic variable. We agree
therefore that expression of the nm23 gene may be an impor-
tant marker for predicting tumour metastasis and outcome of
disease; perhaps identifying a group of patients who might
benefit from adjuvant therapy.
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